Table 2—

Baseline demographic characteristics of the clinical trial population by study group

CCM groupPROV groupUC groupP value
n303851
Age (years)69.7 ± 10.764.4 ± 8.968.6 ± 8.60.04
Age at diagnosis (years)60.0 ± 12.453.1 ± 12.455.8 ± 12.60.09
Duration (years)10.3 ± 8.411.5 ± 9.013.1 ± 10.90.46
Sex (male)50.0 (15)39.5 (15)58.8 (30)0.2
Race (nonwhite)13.3 (4)2.6 (1)9.8 (5)0.26
Education (less than a high school education)50.0 (15)57.9 (22)60.8 (31)0.63
Income (<$20,000/year)44.4 (12)52.8 (19)44.4 (20)0.72
Insulin use26.7 (8)42.1 (16)25.5 (13)0.2
Microvascular complications28.6 (26)18.3 (13)23.3 (17)0.31
Macrovascular complications20.6 (67)18.0 (32)19.6 (49)0.79
Any complication63.8 (88)47.7 (42)57 (61)0.06
  • Results are % (n) or means ± SD.